Xiaobao Chen, Jiang Wei, Ruoyun Xie, Huaiying Zheng. "Intravesical gemcitabine and docetaxel combined with intravenous tislelizumab as a durable strategy for high-risk non–muscle-invasive bladder cancer.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.703